The levels of neopterin, biopterin and the neopterin/biopterin ratio (NIB) were measured in urine samples taken from normal young and elderly control subjects, exceptionally healthy elderly control subjects classified according to the 'Senieur' protocol and patients with Down t s syndrome ( DS ) or Alzheimer's disease (AD). The NIB ratio was approximately unity in the control groups with the exception of the normal elderly controls. The levels of neopterin and biopterin declined with age in the exceptionally healthy 'Senieur' control group. The NIB ratio was elevated in young and old DS patients as a result of a significant increase in neopterin. Neopterin levels were significantly elevated in AD patients compared with the healthy elderly controls, but this did not result in a significant increase in the NIB ratio in these patients. The NIB ratio increased with age in AD patients as a result of a decline in biopterin. These results suggested that there is a cellular immune response in DS and AD patients which in DS, may precede the formation of J3-amyloid deposits in the brain. In addition, there may be a deficiency in tetrahydrobiopterin biosynthesis in AD which becomes more marked with age .
Introduction
Pterins are common in the brain and are important in the production of monoamine neurotransmitters (1) (2) (3) (4) . Both biopterin and neopterin have been isolated from human urine (5) (6) (7) . Biopterin in urine probably results from the metabolism of tetrahydrobiopterin (BH4)' BH4 is oxidised to quininoid dihydrobiopterin and converted to 7,8-dihydrobiopterin before being excreted. By contrast, neopterin in urine may be derived either from dihydroneopterin triphosphate (NH 2 P 3 ), an intermediate in the pathway of BH4 § Author to whom correspondence should be addressed.
synthesis from guanosine triphosphate or may be secreted in large quantities by macrophages activated by interferon-gamma (IFN-y) (9, 10) . This is because IFN-g stimulates the production of guanosine triphosphate cyclohydrolase (GTP-CH) relative to the enzyme 6-pyruvoyl-tetrahydropterin synthase (PTPS) which, in most cells, converts 7,8-dihydroneopterin triphosphate to BH4 rather than to neopterin. Hence, elevated urinary neopterin could be a marker of a cellular immune response in a patient (11) . In the normal healthy adult, the ratio of neopterin to biopterin (NIB) is approximately unity (12, 13) . Changes in the NIB ratio in plasma or urine may occur as a result of neurological and neurodegenerative disease .
First, defects in the pathway of BH4 synthesis e.g. in PTPS could increase NIB ratios by reducing the level of biopterin (14) . Second, an increased NIB ratio could arise from elevated neopterin as a consequence of a cellular immune response. Third, low levels of dihydropteridine reductase (DHPR) may result in lower NIB ratios since the activity of this enzyme maintains the cellular level of BH4 (IS). Hence, the objectives of this study were to determine whether there were differences in the NIB ratio between:-1) normal and exceptionally healthy control subjects, 2) control subjects and patients with Alzheimer's disease (AD) or Down's syndrome (DS) and 3) whether such changes could be attributable to increases in neopterin andlor reductions in biopterin.
Materials and Methods

Materials
Chemicals used in this study were of Analar or equivalent grade and were supplied either by Sigma Chemical Co. Ltd, Poole, Dorset, England or by Dr B. Schirks Laboratories, Jona, CH-864S, Switzerland.
Urine samples
Urine samples were taken from three groups of control subjects: -1) a group of elderly controls from the United Kingdom (UK) (n=S, mean age 7S±4.6 yrs) none of which were under medication, suffering from a viral infection or malignant disease; 2) a group of young UK controls (n = 6, mean age = 2S± 1.7 yrs) and 3) a group of elderly Austrian controls. The Austrian controls were divided into: -1) an exceptionally healthy control group classified according to the 'Senieur' protocol (n = 10, mean age = Sl± S.9 yrs) and 2) the remainder, designated as 'non-Senieur' controls (n = 11, mean age = SO±S.l), which did not meet the rigorous criteria for inclusion in the 'Senieur' control group. For inclusion in the 'Senieur' group, individuals had to be free from infection, inflammation, immune disease, cardiac insufficiency and malnutrition. Urine samples from Austrian controls were collected and transported the same day at -20°C. On arrival, they were immediately frozen at -70°C. Urine samples were also taken from two groups of patients: -1) an AD group (n = 22, mean age 79±7.7 yrs) and 2) a DS group divided into a younger group (n = 26, mean age=7±7.6yrs) and an older group (n=27, Pteridines/Vol. 6 /~o. 4 Armstrong et al. : Neopterin/Biopterin Ratio mean age 50± 12.7 yrs). All DS patients had the characteristic phenotype and were diagnosed as trisomy 21. Demented patients were clinically diagnosed as probable AD by a consultant geriatrician using NINCDS/ADRDA criteria (16). All AD and DS patients were free from infectious and malignant disorders. However, the AD patients were being treated with a variety of sedatives. All samples of urine were stored as a 1 % solution of free ascorbic acid at -70 0 until use.
Analysis of urine
Urine samples were completely defrosted, oxidised and analysed for neopterin and biopterin by High Performance Liquid Chromatography (HPLC) using the method of Fukushima and Nixon ( 13 ) . Total neopterins and biopterins were measured and not the concentration of the natively oxidised species. 1 rnl of urine was acidified with 0.25 ml of concentrated hydrochloric acid and oxidised in the dark with between 1 and 3 rnl of 3% iodine. After 1 hr, a small amount of free ascorbic acid was added to remove the excess iodine and 100 J..lI of the sample was diluted in 2.9 ml of glass distilled water. 20 J..lI of this solution was injected onto a HPLC column. Urinary creatInIne levels were measured spectrophotometrically using the method of Heinegard and Tiderstrom (17) . Levels of biopterin and neopterin were expressed using the level of creatinine as a baseline (IS).
Statistical analysis
The data were analysed by a one-way analysis of variance, with comparisons between group means by Dunnett's 't' test. This test uses a more rigorous criterion for assessing the significance of differences between means since multiple group comparisons are being made ( 19) . Relationships between the levels of neopterin, biopterin, NIB ratio and patient age were tested using Pearson's correlation coefficient.
Results
Levels of neopterin, biopterin and the NIB ratio in control and patient groups are shown in Table 1 . The NIB ratio was significantly elevated in elderly UK controls compared with young UK controls. In addition, the NIB ratio was elevated in young and old DS patients compared with all control groups and in DS compared with AD. However, the NIB ratio was not significantly different in AD compared with the control groups : No significant differences were found in the levels of neopterin between control groups . However, the level of neopterin was elevated in young and old DS groups compared with all control groups. Neopterin was also elevated in AD but only when compared with the exceptionally healthy 'Senieur' control group . Although the level of neopterin was higher in DS than AD, this difference did not reach statistical significance . The level of biopterin was elevated in young controls compared with the 'Senieur' and 'non-Senieur' control groups. In addition, biopterin was elevated in AD compared with 'non-Senieur' and 'Senieur' controls and in DS compared with 'non-Senieur' controls. Correlations between neopterin, biopterin, the NIB ratio and patient age are shown in Table 2 .
Neopterin levels were negatively correlated with age in the 'non-Senieur' ( P<O.OS) and 'Senieur' controls (P<O .OS ) and the level of biopterin was negatively correlated with age in the 'Senieur' controIs ( P<O .OS). Within the patient groups, neopterin was negatively correlated with age in the young DS group while biopterin and the NIB ratio were negatively and positively correlated with age respectively in the AD group.
Discussion
With the exception of the elderly UK group, the NIB ratio was approximately unity as reported in previous studies (13, 20, 21) . The elevation of the NIB ratio in elderly UK controls relative to the young controls appears to be due to a reduction in biopterin relative to the level of neopterin. Levels of biopterin and neopterin were exceptionally low in the Austrian controls (22). It is possible that the low levels could be attributable to the decomposition of the dihydroforms but the precautions taken during shipment should have reduced this effect. In addition, neopterin and biopterin were negatively correlated with age in 'Senieur' controls while neopte-rin was negatively correlated with age in 'non-Senieur' controls. The decline in biopterin suggests reduced BH4 biosynthesis with age while the fall in neopterin with age in healthy controls could have been due to patients with lower neopterin levels living longer. The data suggest that the N/B ratio is elevated in patients with DS as a result of an increase in the level of neopterin. In addition, neopterin measurements increase more when compared against age matched controls (11) suggesting increase relative to baseline is an important effect. Increased neopterin could result from defects in the pathway of BH4 biosynthesis in normal cells or to the activity of activated macrophages. An increase in neopterin derived from NH 2 P 3 should also decrease the level of biopterin. However, in our DS subjects levels of biopterin were either unchanged compared with normal controls or elevated compared with healthy controls which would support the second hypothesis. If elevated neopterin in DS is due to immune activation, several factors could be involved. First, DS patients are particularly prone to infectious disorders (23) but this is an unlikely explanation since care was taken to exclude such patients from the study. Second, it could be due to an immune reaction resulting from thyroid disease (24) . However, the degree to which thyroid disease is associated with DS is controversial (25) . Third, the immune reaction could result from pathological changes in the brain in DS. In both AD and DS, f3-amyloid is deposited in the brain in the form of senile plaques (26) and an immune reaction could be a response to the formation of this protein (27) . /3-amyloid in the form of early 'diffuse' plaques may be formed in DS patients 13-20 years of age and mature amyloid plaques 10-15 years later (28) . However, elevated neopterin was observed in DS patients much younger than 13 years suggesting that an immune reaction might be involved in initiating the pathology in DS and lead to the deposition of f3-amyloid (29) . Against this hypothesis, the level of neopterin declined with age in the young DS group suggesting that the elevation of neopterin in young DS may have a different explanation to that of adult patients.
N eopterin levels were also elevated in AD compared with healthy controls. However, this did not lead to a significant increase in the N/B ratio in this patient group since:-1) neopterin levels were not raised to the levels observed in DS and 2) biopterin levels were slightly higher in AD compared with older DS patients. As in DS, elevated neopterin in AD may reflect an immune disorder. There is considerable evidence for immune activation in AD patients (30) but its significance relative to AD pathology remains to be established (29) . The N/B ratio increases with age in the AD group as a consequence of the reduced biopterin with age. Defects in BH4 biosynthesis caused by deficiencies in GTP-CH (31) or in PTPS (14) might be responsible for the reductions in biopterin. Elevated N/B ratios have also been reported in depression (32, 33) as a result of an elevation of neopterin and a reduction in biopterin. Since defects in serotonin and in the catecholinergic systems are characteristic of depression (33) , these changes may have a different origin from those of AD. Hence, examination of the urinary N/B ratio and changes in individual pterins could help to elucidate the fundamental defects in depressed and demented patients.
